BIOCRYST PHARMACEUTICALS INC
BCRX · NASDAQ
Updated at 2026-10-15 07:53:16
- Today's High
- $8.18
- Today’s Low
- $7.97
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $8.02
- Previous Close
- $8.05
- Volume
- 5.63M
- Market Cap
- $2.05B
- P/E Ratio
- --
- EPS
- $-1.50
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 4505 EMPEROR BOULEVARD, DURHAM, NC, UNITED STATES, 27703
- Country
- US
- Listing Date
- 1994-03-04
- Fiscal Year End
- December
- Shares Outstanding
- 254.16M
- CIK
- 0000882796
- Website
- www.biocryst.com
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
Financial Metrics
Revenue
2026-06-30
$218.25M
2026-03-31
$156.41M
2025-12-31
$406.55M
2025-09-30
$159.39M
Operating Expenses
2026-06-30
$115.94M
2026-03-31
$154.87M
2025-12-31
$136.64M
2025-09-30
$127.28M
Net Income
2026-06-30
$78.39M
2026-03-31
-$721.81M
2025-12-31
$245.84M
2025-09-30
$12.89M
Net Profit Margin
2026-06-30
35.91%
2026-03-31
-461.47%
2025-12-31
60.47%
2025-09-30
8.09%
Earnings Per Share
2026-06-30
$0.30
2026-03-31
$0.14
2025-12-31
$1.12
2025-09-30
$0.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$98.69M
2026-03-31
-$699.96M
2025-12-31
$266.19M
2025-09-30
$32.12M
Effective Tax Rate
2026-06-30
1.35%
2026-03-31
-0.13%
2025-12-31
0.87%
2025-09-30
-6.33%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $218.25M | $156.41M | $406.55M | $159.39M |
| Operating Expenses | $115.94M | $154.87M | $136.64M | $127.28M |
| Net Income | $78.39M | -$721.81M | $245.84M | $12.89M |
| Net Profit Margin | 35.91% | -461.47% | 60.47% | 8.09% |
| Earnings Per Share | $0.30 | $0.14 | $1.12 | $0.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $98.69M | -$699.96M | $266.19M | $32.12M |
| Effective Tax Rate | 1.35% | -0.13% | 0.87% | -6.33% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.